Jeroen van der Velden is currently the Team Lead of Assay Development at Amarna Therapeutics B.V., a role held since 2020. Previously, Jeroen contributed significantly to the company in various capacities including Scientist and Process Manager, focusing on R&D for viral vaccine products and assay development. With a background that includes a Bachelor of Science in Medical Biotechnology, Jeroen has extensive experience in molecular breeding and developing gene therapy vaccines. They begun their career at Syngenta, where they were involved in generating transgenic plants, and later honed their skills at Viruvation B.V. in producing antibody cell lines.
Location
Leiden, Netherlands
This person is not in any offices